Sort   by:  
 Page size 
ProteomicsStructural and Functional Glycosylation of the Abdala COVID-19 Vaccine
Abdala is a COVID-19 vaccine produced in Pichia pastoris and is based on the receptor-binding domain (RBD) of the SARS-CoV-2 spike. Abdala is currently approved for use in multiple countries with clinical trials confirming its safety and efficacy in preventing severe illness and death. Although P. p...
ORGANISM(S): Homo sapiens (Human) 
2025-05-07 | PXD058644 | Pride
Glycosylation Covid Sars Abdala 
ProteomicsNipah G glycosylation site provides stability for receptor engagement
Nipah virus is a deadly paramyxovirus with 40-75% mortality and >750 cases since 1998. Currently there are no clinically approved vaccines or therapeutics to target infection. Nipah is an enveloped virus with two surface glycoproteins, the trimeric fusion (F) and tetrameric attachment glycoprotein (...
ORGANISM(S): Homo sapiens (Human) 
2026-03-30 | PXD062381 | Pride
ProteomicsAn N-glycan on the C2 domain of Jagged-1 is essential for Notch activation
Glycoproteomics determination of human jagged-1 glycan composition
ORGANISM(S): Homo sapiens (Human) 
2022-10-17 | PXD034133 | Pride
Glycoproteomics Jagged1 
ProteomicsAn N-glycan on the C2 domain of Jagged-1 is essential for Notch activation
Glycoproteomic determination of human Jagged-1 glycan composition
ORGANISM(S): Homo sapiens (Human) 
2023-06-28 | PXD034130 | Pride
293f Glyoproteomics Jagged-1 293s 
Sort   by:  
 Page size